Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Cymbalta (Duloxetine HCl) for Chronic Musculoskeletal Pain Management

Eli Lilly conducted phase III clinical trials on Cymbalta from July 2009 to May 2010. The study enrolled 420 patients and compared the efficacy of 60mg of Cymbalta to a placebo to assess the effect of the drug in reducing the pain effect caused by knee osteoarthritis.

Go Top